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Abstract
Nkx2.2 and NeuroD1 are vital for proper differentiation of pancreatic islet cell types. Nkx2.2-null mice fail to form β cells, have reduced
numbers of α and PP cells and display an increase in ghrelin-producing ε cells. NeuroD1-null mice display a reduction of α and β cells after
embryonic day (e) 17.5. To begin to determine the relative contributions of Nkx2.2 and NeuroD1 in islet development, we generated Nkx2.2−/−;
NeuroD1−/− double knockout (DKO) mice. As expected, the DKO mice fail to form β cells, similar to the Nkx2.2-null mice, suggesting that the
Nkx2.2 phenotype may be dominant over the NeuroD1 phenotype in the β cells. Surprisingly, however, the α, PP and ε phenotypes of the Nkx2.2-
null mice are partially rescued by the simultaneous elimination of NeuroD1, even at early developmental time points when NeuroD1 null mice
alone do not display a phenotype. Our results indicate that Nkx2.2 and NeuroD1 interact to regulate pancreatic islet cell fates, and this epistatic
relationship is cell-type dependent. Furthermore, this study reveals a previously unappreciated early function of NeuroD1 in regulating the
specification of α, PP and ε cells.
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The pancreas is a multifunctional organ consisting of
exocrine and endocrine components, which is essential for
maintaining glucose homeostasis and energy metabolism in the
body. In developing mice, the pancreatic islets consist of five
major endocrine cell types; insulin-producing β cells, glucagon-
producing α cells, somatostatin-producing δ cells, pancreatic
polypeptide (PP)-producing PP cells and ghrelin-producing ε
cells. In addition, there exists a small population of islet cells
that co-express ghrelin and glucagon and appear to be distinct
from either the α cell or ε cell lineage (Heller et al., 2005).
Several mouse models have demonstrated that individual
transcription factors, such as Pdx1, Hnf6, Ngn3, NeuroD1,
Nkx2.2, Nkx6.1, Pax4 and Pax6, are essential for islet cell
differentiation, maintenance and proper organization (Collom-⁎ Corresponding author. Department of Genetics and Development, 1150 St.
Nicholas Avenue, Room 607B, New York, NY 10032, USA.
E-mail address: lgs2@columbia.edu (L. Sussel).
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doi:10.1016/j.ydbio.2007.09.057bat et al., 2003; Gannon et al., 2000; Gradwohl et al., 2000;
Jacquemin et al., 2000; Jonsson et al., 1994; Naya et al., 1997;
Offield et al., 1996; Sander et al., 2000; Sosa-Pineda et al.,
1997; St-Onge et al., 1997; Sussel et al., 1998). Elimination of
each of these transcription factors gives rise to a pancreatic
defect at a distinct developmental stage, thus allowing for the
organization of these factors into a genetic regulatory cascade
(Gasa et al., 2004; Habener et al., 2005; Schwitzgebel, 2001).
More recently, sophisticated genetic approaches have been used
to show complex temporal requirements and novel functions for
several of these regulatory factors. Inducible activation of Pdx1
at discrete embryonic time points demonstrates that it functions
at multiple stages of pancreas development, as well as in the
adult to regulate pancreatic differentiation and function (Hol-
land et al., 2005; Holland et al., 2002). Furthermore, double
knockout studies have revealed novel roles for Pax4, Arx,
Nkx6.1 and Nkx6.2 regulatory factors in islet cell type
specification (Collombat et al., 2005; Henseleit et al., 2005).
In this study, we focus on two essential islet regulatory
proteins, Nkx2.2 and NeuroD1/Beta2 (hereafter referred to as
524 C.S. Chao et al. / Developmental Biology 312 (2007) 523–532NeuroD1). Nkx2.2 is a homeodomain-containing protein that is
expressed in the central nervous system, pancreas and intestine.
Nkx2.2 is present in the earliest progenitor cells of the
developing pancreas and gradually becomes restricted to β
cells and a subset of α and PP cells (Sussel et al., 1998). In the
absence of Nkx2.2, β cells fail to differentiate and α and PP cell
numbers are reduced. Interestingly, the ghrelin-producing ε cell
population appears to replace these islet cell types, implicating
Nkx2.2 as a major regulator of the initial islet cell fate decisions
(Prado et al., 2004). NeuroD1 is a basic helix–loop–helix
(bHLH) transcription factor, which is also expressed in the
central nervous system, pancreas and intestine. In the pancreas,
NeuroD1 expression begins at the onset of pancreatic bud
formation and by e10.5, NeuroD1 is restricted to the endocrine
cell population (Chu et al., 2001; Naya et al., 1997). In
NeuroD1−/− mice, the pancreas develops without any discern-
able phenotypes until e15.5; however, islets fail to form and
increased islet cell death is apparent by e17.5 (Naya et al.,
1997). These analyses suggest that NeuroD1 may not be
required for initial islet cell specification but may play a
predominant role in islet cell differentiation and survival. The
phenotypes of the individual Nkx2.2 null and NeuroD1 null
mice suggest that Nkx2.2 functions upstream of NeuroD1 in the
genetic cascade; however, it remains unclear what role each of
these transcription factors plays in the early pancreatic
primordia and whether they genetically interact to control
islet cell development.
To clarify the relative roles of Nkx2.2 and NeuroD1 in the
development of the individual islet cell populations, we
generated Nkx2.2−/−;NeuroD1−/− double knockout (DKO)
mice. We found that the Nkx2.2−/−;NeuroD1−/− DKO mice
failed to form insulin-producing β cells, similar to what was
observed in the single Nkx2.2−/− mice. Unexpectedly, how-
ever, we observed a significant recovery of α cells and PP cells
in the Nkx2.2−/−;NeuroD1−/− DKO mice, compared to the
Nkx2.2−/− single knockout mice. Furthermore, there appeared
to be a corresponding decrease of the ghrelin-producing ε cells
in Nkx2.2−/−;NeuroD1−/− DKOmice compared to Nkx2.2−/−
mice. Interestingly, this partial restoration of normal α, PP and ε
cell ratios was evident during a major wave of islet cell
differentiation, termed the secondary transition (Pictet and
Rutter, 1972), which is prior to an observed NeuroD1 single
knockout phenotype. These results suggest that NeuroD1 has a
previously unknown role in regulating islet cell fate specifica-
tion prior to e15.5. In addition, these studies reveal a complex
genetic interaction between Nkx2.2 and NeuroD1 that is
responsible for the specification of α, PP and ε cell fates.
Materials and methods
Animals
Nkx2.2 and NeuroD1 heterozygous mice were generated by homologous
recombination as previously described (Miyata et al., 1999; Sussel et al., 1998).
Nkx2.2+/− and NeuroD1+/− animals were maintained in a Swiss Black
(Taconic) background. All mice that were homozygous for the NeuroD1 null
allele on this genetic background died shortly after birth and displayed no
variability in phenotype. Double heterozygous mice were mated to obtain DKOmice. Genotyping of mice and embryos was performed by PCR analysis. The
Nkx2.2 wild-type locus was identified with primers as previously described
(Sussel et al., 1998). In order to detect the Nkx2.2 null allele, we used a forward
primer (5′-cagcgatgggaaggagagatttca-3′) to detect sequence within the 5′
Nkx2.2 promoter and a reverse primer (5′-gatcagcagcctctgttccacata-3′) homo-
logous to sequences within the PGK1-neo gene. To genotype NeuroD1, we used
a forward primer (5′-accatgcactctgtacgcatt-3′) that recognized sequences within
the 5′NeuroD1 promoter and two reverse primers, one within the LacZ gene (5′-
gagaactgagacactcatgtg-3′) and one within the NeuroD1 locus (5′-aaacgccgagt-
taaagccatc-3′) to identify the knockout and wild-type alleles, respectively.
Animals were housed and treated according to UCHSC Institutional Review
Board approval protocols.
Immunofluorescence
Immunofluorescence was performed on e12.5, e15.5, e16.5 and P0
cyropreserved tissue fixed with 4% paraformaldehyde at 4 °C for 3 h (MafA)
or overnight (Arx, ghrelin, glucagon, insulin, somatostatin, PP). A subset of
P0 pancreatic tissue was dissected and fixed with 10% formalin for 1.5 h
(Nkx6.1, Pdx1 and Pax6). Antibodies used were rabbit anti-amylase (1:1000,
Sigma), rabbit anti-Arx (1:1000, P. Collombat, Goettingen, Germany), guinea-
pig anti β-galactosidase (1:1000, T. Finger, University of Colorado Health
Science Center), rabbit anti-ghrelin (1:200, Phoenix), guinea-pig anti-glucagon
(1:3000, Linco), guinea-pig anti-insulin (1:1000, Linco), rabbit anti-MafA
(1:1000, Bethyl), rabbit anti-Nkx6.1 (1:800, Beta Cell Biology Consortium
(BCBC)), rabbit anti-Pax6 (1;1000, Chemicon), rabbit anti-Pdx1 (1:1000,
Chemicon), guinea-pig anti-pancreatic polypeptide (1:500, Linco) and rabbit
anti-somatostatin (1:200, Phoenix). Secondary antibodies used were Alexa-
fluor-488 anti-rabbit (1:400), Alexafluor-488 anti-guinea pig (1:400), Alexa-
fluor-594 anti-guinea pig (1:400) and Alexafluor-594 anti-rabbit (1:400).
Confocal images were processed with a Zeiss Microscope, LSM 510 META at
25× magnification.
Morphometric analysis
For each genotype (wild-type, Nkx2.2−/−, NeuroD1−/− and Nkx2.2−/−;
NeuroD1−/−), e16.5 embryos and P0 mice were processed as above and every
10 sections were collected and stained by immunofluorescence for ghrelin and
glucagon. For morphometric analysis, n=3 at each time point. Non-overlapping
images of the total pancreatic area were taken at 10× magnification for counting
of fluorescent cells and total pancreatic area on a Leica CTR 5000.
Immunofluorescent cell area on glucagon+, ghrelin+ and glucagon+ghrelin+
sections was counted and then divided by total pancreatic area using
morphometric analysis in Image Pro Plus 5.1 software. Results are shown as
percent fluorescent area per total pancreatic area. Significance was calculated
using the two-tailed Student's t-test with unequal variance. A p value of b0.05
was considered statistically significant.
Quantification of mRNA by real-time Taqman PCR
Total RNA was isolated with the RNeasy Micro Kit (Qiagen) from whole
pancreas and small intestine at P0. For each tissue, mRNA (2ug) was converted
into cDNA using superscript III (Invitrogen). Quantitative PCR (qPCR)
for Brn4 (Mm00447171_S1), cholecystokinin (Mm00446170_m1),
gapdh (Mm99999915_g1), ghrelin (Mm00445450_m1), glucagon
(Mm00801712_m1), insulin II (Mm00731595_gH), Irx2 (Mm01340316_m1),
NeuroD1 (Mm01280117_m1), pancreatic polypeptide (Mm00435889_m1),
Pdx1 (Mm00435565_m1), secretin (Mm00441235_g1) and somatostatin
(Mm00436671_m1) was performed using Assay on Demand primer/probe sets
(Applied Biosystems). Primer/probe sets were designed for Nkx2.2, Nkx6.1,
MafA, Pax4 and Pax6 (Doyle et al., 2007). The probe, forward primer and reverse
primer sequences for Arx were FAM-ctaccgcaccacgttcaccagt-MGB, 5′gaagcg-
caaacagagg3′ and 5′gctccagttcctccag3′, respectively. All qPCR was performed
on the ABI PRISM 7000 Sequence Detection System. An n=5–6 was
obtained for wild-type, Nkx2.2−/−, NeuroD1−/−, Nkx2.2−/−; NeuroD1−/−,
Nkx2.2−/−NeuroD1+/− and Nkx2.2+/−NeuroD1−/−. A p value of b0.05 were
considered statistically significant.
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RNA in situ hybridization was performed as previously described (Prado et
al., 2004) using antisense riboprobes transcribed from linearized plasmids on
processed tissue (described in the Immunofluorescence section). Riboprobes
for Nkx2.2 and Ngn3 were made from PCR-cloned full-length cDNAs (Decker
et al., 2006; Sussel et al., 1998). The riboprobe for Brn4 was generated from
full length Brn4 cDNA PCR amplified from a pancreatic cDNA library (Prado
et al., 2004) and cloned into the TOPO blunt vector (Invitrogen). NeuroD1, Arx
and Irx2 riboprobes were generated from the plasmids pCS2:MTmNeuroD1 (J.
Lee.), pYX-Asc-Arx (Open Biosystems) and pYX-Asc-Irx2 (Open Biosys-
tems), respectively. RNA in situ hybridization was performed on tissue from
Nkx2.2−/−, NeuroD1−/− and Nkx2.2−/−;NeuroD1−/− embryos and a
corresponding number of wild-type littermates at e12.5, e16.5 and P0.
Results
The Nkx2.2−/−;NeuroD1−/− DKO mice fail to form
insulin-producing β cells
To determine the potential molecular and genetic interactions
between Nkx2.2 and NeuroD1 during islet development, we
generated Nkx2.2−/−;NeuroD1−/− DKO mice. Since the
presence of the NeoR gene in both the Nkx2.2 and NeuroD1
mutant alleles was previously used for genotyping, weFig. 1. Insulin-producing β cells are absent in Nkx2.2−/−;NeuroD1−/− DKO mice.
(e–h) pancreas of wild-type, NeuroD1−/−, Nkx2.2−/− and Nkx2.2−/−;NeuroD1−/−
Quantitative PCR results for mRNA of Nkx2.2, NeuroD1 and insulin in P0 pancreas
(i). n=3–6 pancreas per genotype. Significance was calculated using the two-tailed
asterisk (*) compared to wild-type phenotype.developed new PCR primer sets to distinguish each of the
alleles (Materials and methods) and verified the genotypes
using quantitative real-time PCR for detection of the Nkx2.2
and NeuroD1 mRNA (Fig. 1). This analysis confirmed the
efficacy of our new genotyping primers. Interestingly, the
assessment of gene expression also demonstrated that NeuroD1
is downregulated in the islets of Nkx2.2−/− mice (Fig. 1i). We
further explored the reduction in NeuroD1 expression in the
Nkx2.2−/− mice by comparing the expression of β-galactosi-
dase (the lacZ gene is inserted into the NeuroD1 locus; Miyata
et al., 1999) in wild-type and Nkx2.2−/− mice at e12.5 and
e18.5 (Fig. 2 and data not shown). The immunohistochemical
analysis of β-galactosidase expression confirms that NeuroD1
is expressed in reduced numbers of cells in the Nkx2.2−/−mice,
possibly partially due to the loss of specific islet cell types.
Nkx2.2 mRNA expression is not significantly changed in the
NeuroD1−/− knockout at each stage of development tested
(Fig. 1 and data not shown).
We next examined Nkx2.2−/−;NeuroD1−/− DKO mice at
e12.5, e15.5, e16.5 and P0 and compared them to the single
knockout phenotypes. Similar to the Nkx2.2-null mice,
Nkx2.2−/−;NeuroD1−/− DKO mice do not contain insulin-
producing cells at any developmental time point (Figs. 1a–hImmunofluorescence of insulin (green) and amylase (red) in e16.5 (a–d) and P0
DKO mice. Islet clusters are outlined by the dotted lines with no insulin staining.
of wild-type, NeuroD1−/−, Nkx2.2−/− and Nkx2.2−/−;NeuroD1−/− DKO mice
Student's t-test with unequal variance. A p value of b0.05 is indicated by an
Fig. 2. NeuroD1 expression in Nkx2.2−/− islets. Immunofluorescence of glucagon (green) and β-galactosidase (red) in e12.5 tissue. The β-galactosidase signal
reflects NeuroD1 expression since the cytoplasmic LacZ gene has been knocked into the NeuroD1 genomic locus. Nkx2.2+/+; NeuroD1+/− at 20× (a, b) and 40× (e, f)
magnification. Nkx2.2−/−; NeuroD1+/− at 20× (c, d) and 40× (g, h) magnification.
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expression was confirmed by quantitative PCR at P0 (Fig.
1i). The single knockout phenotypes suggest that Nkx2.2 is
required for β cell fate determination and specification,
whereas NeuroD1 appears to be necessary for the subsequent
differentiation and survival of β cells at subsequent develop-
mental stages. The Nkx2.2−/−;NeuroD1−/− DKO phenotype
supports the single knockout data; however, the complete
absence of β cells in the Nkx2.2−/− mice precludes our ability
to make additional conclusions about the relative roles of
Nkx2.2 and NeuroD1 in the β cell.
The aberrant ratios of glucagon-producing cells and
ghrelin-producing cells found in Nkx2.2−/− mice are partially
restored in Nkx2.2−/−;NeuroD1−/− DKO mice
In the Nkx2.2−/− mice, only a small fraction of glucagon-
producing α cells form (Sussel et al., 1998). In the NeuroD1−/−
mice, α cells form in their normal numbers; however, there is a
50% reduction in α cells at e16.5, the molecular basis of which
is unknown (Naya et al., 1995). Surprisingly, at e12.5 and e15.5,
which is prior to any apparent NeuroD1−/− single knockout
phenotype, α cell numbers are partially restored in the islets of
the Nkx2.2−/−;NeuroD1−/− DKO mice. These results would
suggest that the absence of NeuroD1 in the Nkx2.2−/− genetic
background allowed for partial recovery of the α cell population
(Figs. 3 and 4, and data not shown). In the newborn Nkx2.2−/−;
NeuroD1−/− DKO mice, the recovered α cell population is
present at approximately 50% of wild-type levels (Figs. 3a–h
and 4), which is significantly higher than observed in the
Nkx2.2−/− mice. On the other hand, the amount of α cells that
are recovered is similar to the numbers observed in the late
gestation NeuroD1−/− mice, suggesting that NeuroD1 function
may still be required in the Nkx2.2−/−;NeuroD1−/− DKO for
full maintenance of the α cell population. Quantitative PCR
analyses confirm that glucagon mRNA expression levels
corresponded to the relative numbers of glucagon-producingcells in each genotypic background (Fig. 3). Interestingly, an
intermediate number of α cells are restored in the Nkx2.2−/−;
NeuroD1+/− mice (Figs. 3i and 4c–d), suggesting that the
dosage of NeuroD1 activity may play an important role in
determining the number of α cells recovered in the absence of
Nkx2.2. Similar dosage effects were not observed in Nkx2.2+/−;
NeuroD1−/− mice, which had an α cell phenotype indistin-
guishable from that of the NeuroD1−/− mice (data not shown).
These findings suggest that Nkx2.2 and NeuroD1 have
interrelated functions in the differentiation of glucagon-produ-
cing α cells and the absence of Nkx2.2 uncovers novel NeuroD1
activities in α cell specification.
In the Nkx2.2−/− mice, the loss of glucagon-producing α
cell formation is accompanied by a corresponding increase in
ghrelin-producing ε cell numbers and a loss of the minor
glucagon+ghrelin+ co-expressing cell population (Prado et al.,
2004). In the NeuroD1−/− mice, ghrelin appears unchanged at
both the mRNA and protein levels in all ages examined (Figs. 3
and 4). To determine the status of the ghrelin-producing and
ghrelin+glucagon+ populations in the Nkx2.2−/−;NeuroD1−/−
DKO mice, we assessed ghrelin mRNA and protein expression
at e16.5 and/or P0. Interestingly, although not reduced to wild-
type levels, ε cell numbers were decreased approximately 50%
in the Nkx2.2−/−;NeuroD1−/− DKO mice compared to the
Nkx2.2−/− mice (Fig. 4b). The decrease in ε cell numbers
corresponded with the observed increase in the α cell numbers.
We confirmed that the alteration in the relative glucagon- and
ghrelin-producing cell numbers was not due to an abnormal
increase in the glucagon+ghrelin+ double positive cell popula-
tion; however, this minor cell population was fully recovered to
wild-type levels compared to the Nkx2.2 null mice (Figs. 4a, b).
These results suggest that the glucagon-producing α cell
population has been restored at the expense of the ghrelin-
producing ε cell population and further implicates an important
role for NeuroD1 in these early islet cell fate decisions.
The Nkx2.2−/− mice also display a partial loss of PP cells
(Sussel et al., 1998), while the PP cell population appears to be
Fig. 3. Glucagon-producing α cells and Ghrelin-producing ε cells partially restored in Nkx2.2−/−;NeuroD1−/− DKO mice. Immunofluorescence of glucagon (red)
and ghrelin (green) in e16.5 (a–d) and P0 (e–i) tissue of wild-type, NeuroD1−/−, Nkx2.2−/−, Nkx2.2−/−;NeuroD1−/− DKO and Nkx2.2−/−NeuroD1+/− mice.
Immunofluorescence of PP (green) and somatostatin (red) in P0 (j–m) tissue of wild-type, NeuroD1−/−, Nkx2.2−/− and Nkx2.2−/−;NeuroD1−/− DKO mice.
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Interestingly, PP cells are restored to wild-type levels in the
Nkx2.2−/−;NeuroD1−/− DKO mice (Figs. 3m and 4e), sug-
gesting that Nkx2.2 and NeuroD1 also genetically interact in
this cell fate determination pathway. The somatostatin-pro-
ducing δ cell populations are unaffected in both single
knockouts and remained unchanged in the Nkx2.2−/−;
NeuroD1−/− DKO mice (Fig. 4e).
The rescued glucagon-producing cell population in the
Nkx2.2−/−;NeuroD1−/− DKO mice express the α cell-specific
factor, Brn4
In the Nkx2.2−/−;NeuroD1−/− DKO mice, approximately
50% of the glucagon-producing cells are recovered compared
with the Nkx2.2−/− mice and we have demonstrated that the
majority of these cells do not co-express either ghrelin or the
other islet hormones (Fig. 4 and data not shown). To further
characterize the glucagon-expressing cells recovered in the
Nkx2.2−/−;NeuroD1−/− DKO, we assessed the expression of
Brn4, a well-characterized α cell-specific marker (Heller et al.,
2004; Jensen et al., 2000). Similar to the recovery of glucagon
expression in these mice, Brn4 expression was partially restored
in the Nkx2.2−/−;NeuroD1−/− DKO (Fig. 5 and Supplemental
Fig. 2). We also analyzed the expression of Arx and Irx2, two
recently described α cell factors (Collombat et al., 2003; Heller
et al., 2005; Petri et al., 2006). Unexpectedly, we observed a
significant upregulation of Arx expression and relatively little
change of Irx2 expression in the Nkx2.2−/− pancreata, in which
α cells are almost completely absent and the majority ofendocrine cells produce ghrelin (Supplemental Figs. 1 and 2).
The expression of both these factors is moderately reduced in
the Nkx2.2−/−;NeuroD1−/− DKO compared to the Nkx2.2−/−
mice, which again does not correlate with the comparative
increase in α cells we observe compared to either single
knockout. To better understand these surprising results, we
assessed the cell types expressing Arx protein (antibodies
against Irx2 were unavailable). Interestingly, in the Nkx2.2−/−
mice, the majority of Arx expressing cells did not co-express
glucagon (Supplemental Figs. 3g and k) and were located in the
region of the islet containing large numbers of ghrelin-
producing cells (Supplemental Figs. 3c and g; the Arx and
ghrelin antibodies are both generated in rabbit, which precluded
double labeling of the two proteins). In the Nkx2.2−/−;
NeuroD1−/− DKO, there still remained a number of Arx+,
glucagon-cells present (Supplemental Fig. 3m); however,
significant numbers of the recovered glucagon-positive cells
now co-expressed Arx (Supplemental Figs. 3h and l). While the
unexpected upregulation of Arx and unchanged Irx2 expression
in the Nkx2.2−/− pancreata somewhat impair the use of these
markers to assess the recovered α cell population in the
Nkx2.2−/−;NeuroD1−/− DKO, it is clear that the newly
recovered α cells do co-express Arx. Furthermore, the
recovered α cells co-express Pax6, which is also highly
expressed in α cells, and do not inappropriately co-express the
β cell transcription factors Nkx6.1, Pdx1 and MafA (Fig. 6).
Consistent with the immunohistochemical analysis, quantita-
tive PCR analysis indicated that Nkx6.1, Pdx1 and MafA
expression is not recovered in Nkx2.2−/−;NeuroD1−/− DKO
mice compared to the Nkx2.2−/− mice (Fig. 6i). Therefore, it
Fig. 4. Quantification of mRNA and islet hormone-positive area. Graphs of the percent immunofluorescent glucagon, ghrelin and glucagon+ghrelin+ cell area per
total pancreatic area from e16.5 (a) and P0 (b) tissues. Every ten sections from 100 sections for each genotype, wild-type, NeuroD1−/−, Nkx2.2−/−, Nkx2.2−/−;
NeuroD1−/− and Nkx2.2−/−NeuroD1+/− mice were counted. n=3 for each genotype in cell area counts. Quantitative PCR results for fold change of glucagon (c)
and ghrelin (d) mRNA in P0 pancreas of wild-type, NeuroD1−/−, Nkx2.2−/−, Nkx2.2−/−;NeuroD1−/− and Nkx2.2−/−NeuroD1+/− mice. Real-time PCR results
for fold change of PP and somatostatin mRNA in P0 pancreas of wild-type, NeuroD1−/−, Nkx2.2−/− and Nkx2.2−/−;NeuroD1−/− DKO mice (e). n=3–6
pancreas per genotype in all qPCRs. Significance was calculated using the two-tailed Student's t-test with unequal variance. A p value of b0.05 is indicated by an
asterisk (*) compared to wild-type and + compared to Nkx2.2 knockout phenotype.
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lation expressing Brn4, Arx and Pax6 is recovered in the
Nkx2.2−/−;NeuroD1−/− DKO mice. Further analysis of the
ghrelin cell population in the Nkx2.2−/− mice will be necessary
to assess why they apparently express the α cell marker, Arx.
Proglucagon-producing cells in the intestine of Nkx2.2−/− are
also recovered in Nkx2.2−/−;NeuroD1−/− DKO mice
The differentiation of the enteroendocrine cell population in
the intestine is regulated by many of the same transcription
factors that regulate islet cell development. Ngn3−/− mice fail
to generate both intestinal and pancreatic endocrine progenitor
cells (Gradwohl et al., 2000; Jenny et al., 2002; Lee et al.,
2002), and Pax4 and Pax6 affect the formation of subsets of
endocrine cells in both organs (Larsson et al., 1998). Several
enteroendocrine cell populations are also reduced in the
Nkx2.2−/− and NeuroD1−/− mice (Fig. 7; Desai et al., in
press; Naya et al., 1995). Similar to the islet phenotype, the
reduction of intestinal endocrine cell populations in Nkx2.2−/−
mice corresponds with an increase in ghrelin-producing cells(Fig. 7 and Desai et al., in press). On the other hand, NeuroD1−/−
mice only lack cholecystokinin (CCK) and secretin-producing
enteroendocrine cells in the intestine (Naya et al., 1995). Given
the regulatory conservation that appears to exist between the
intestinal and pancreatic endocrine populations, we assessed
whether a functional interaction between Nkx2.2 and NeuroD1
also existed in the formation of the enteroendocrine cell
populations both affected by Nkx2.2 and NeuroD1. We
examined mRNA expression levels of CCK, secretin, proglu-
cagon and ghrelin in the Nkx2.2−/−;NeuroD1−/− DKO mice
(Fig. 7). In each single knockout, expression of CCK and
secretin is reduced, but there is no additional reduction or
rescue observed in the DKO mice (Fig. 7 and data not shown).
In contrast, proglucagon expression is significantly reduced
and ghrelin is upregulated approximately 20-fold in the
Nkx2.2−/− mice. These hormones are unaffected in the
NeuroD1−/− mice (Fig. 7). Strikingly, proglucagon expression
is completely restored and ghrelin levels are decreased in the
Nkx2.2−/−; NeuroD1−/− DKO, similar to what we observed
in the pancreas. Our results indicate that Nkx2.2 and NeuroD1
genetically interact to regulate the differentiation of both islet
Fig. 5. Brn4 expression in recovered glucagon cells in Nkx2.2−/−;NeuroD1−/−DKOmice. RNA in situ analysis for Brn4 expression on wild-type (a, e), NeuroD1−/−
(b, f), Nkx2.2−/− (c, g) and Nkx2.2−/−;NeuroD1−/− DKO (d, h) tissue. (e–h) are higher magnification images of staining in panels a–d.
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populations.
Discussion
In this study, we created NeuroD1 and Nkx2.2 DKO mice to
understand the relative roles of these two essential transcription
factors in islet development. Surprisingly, we demonstrated that
there is a unique genetic interaction between Nkx2.2 and
NeuroD1 during α, PP and ε cell differentiation that is only
revealed when Nkx2.2 and NeuroD1 are simultaneously deleted
from the developing pancreas. These observations provide the
first evidence that these two essential regulatory factors can
form cell-type-dependent functional interactions to differen-
tially regulate the individual islet cell fates. Interestingly, it also
appears that Nkx2.2 and NeuroD1 functionally cooperate to
specify the fate decision between L cells and ghrelin cells in the
intestine. In addition, these studies have uncovered a novel role
for NeuroD1 in directing early α, PP and ε cell fate decisionsthat is distinct from its role in later stages of α cell development
and β cell differentiation and survival.
The majority of recent pancreatic islet research has focused
on β cell development due to the importance of β cells in islet
function, as well as their relative abundance compared to the
other islet cell types. As a result of this extensive body of
research, a more defined picture of β cell differentiation is
beginning to emerge. Specifically, many β cell regulators and
markers have been identified and distinct stages of β cell
differentiation have been characterized (Cerf et al., 2005; Doyle
et al., 2007; Holland et al., 2005; Lantz and Kaestner, 2005;
Nishimura et al., 2006; Sosa-Pineda, 2004). The Nkx2.2 and
NeuroD1 single knockout β cell phenotypes suggest that
Nkx2.2 and NeuroD1 function at different stages of β cell
differentiation; Nkx2.2 is required for the initial specification of
all β cells, while NeuroD1 appears to be required for late stage
differentiation and maintenance. Furthermore, NeuroD1 expres-
sion is reduced in the Nkx2.2 knockout mice, whereas Nkx2.2
expression is unchanged in the NeuroD1 mutant, supporting the
Fig. 6. Transcription factor profile of Nkx2.2−/−;NeuroD1−/− DKO mice. Immunofluorescence images at P0 of wild-type (a–d) and Nkx2.2−/−;NeuroD1−/− DKO
(e–h) mice for glucagon (red: a–h) and Nkx6.1 (green: a, e), Pdx1 (green: b, f), MafA (green: c, g) and Pax6 (green: d, h). An enlarged image of panel d shows in wild-
type islets some alpha cells do not normally express Pax6 (arrow). Panels a–h are images taken on a Zeiss LSM 5 confocal microscope at 25×. Panels e′–h′ are 40×
images of the islets shown in panels e–h. Quantitative PCR results for fold change of Nkx6.1, Pdx1 and MafA in P0 pancreas of wild-type, NeuroD1−/−, Nkx2.2−/−
and Nkx2.2−/−;NeuroD1−/− DKO mice (i). n=3–6 pancreas per genotype in qPCR. Significance was calculated using the two-tailed Student's t-test with unequal
variance. A p value of b0.05 is indicated by an asterisk (*) compared to wild-type and + compared to Nkx2.2 knockout phenotype.
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Consistent with this, we do observe a significant reduction of
NeuroD1-expressing cells as early as e12.5 (prior to the
formation of many of the individual islet cell types) and there
appear to be fewer cells expressing high levels of NeuroD1. At
this point, however, we cannot rule out that the downregulation
of NeuroD1 is merely secondary to the loss of specific islet cell
types, especially late in gestation. The fact that the Nkx2.2−/−;
NeuroD1−/− DKO mice display an Nkx2.2 KO phenotype also
suggests that Nkx2.2 is epistatic to NeuroD1, the caveat being
that the complete absence of β cells may preclude observing
phenotypes associated with the NeuroD1 deletion. A condi-
tional mutation of Nkx2.2 is being developed to resolve these
issues and to further explore the relationship between NeuroD1
and Nkx2.2 specifically in the β cell.
In contrast to the β cells, much less is understood about the
regulation of the non-β cell lineages. Although glucagon-
producing α cells are also essential for proper islet function,
little is known about the regulation of α cell formation and the
stages of α cell differentiation. The restoration of the glucagon-
producing α cell population in the Nkx2.2−/−; NeuroD1−/−
DKO mice, compared to the Nkx2.2−/− mice implicates
NeuroD1 as an important regulator of α cell determination.
While these studies are beginning to clarify the role of NeuroD1
in α cell fate determination, the molecular mechanism by which
NeuroD1 operates remains unclear. NeuroD1 is present in
glucagon-producing α cells throughout embryogenesis; how-
ever, the NeuroD1−/− mice do not display an α cell phenotypeuntil late in gestation (Chu et al., 2001; Naya et al., 1997). In
contrast, NeuroD1 activity appears to be required to maintain
repression of the α cell fate in the absence of Nkx2.2.
Furthermore, incremental reductions in NeuroD1 activity, as
seen in the NeuroD1 heterozygous mice, can restore to an
intermediate level the α cell defects associated with loss of
Nkx2.2. We propose that Nkx2.2 may be responsible for the
normal repression of NeuroD1 function in early α cells,
possibly through activation of a negative regulator of NeuroD1,
such as an Id protein (Norton, 2000). Alternatively, Nkx2.2 and
NeuroD1 may function in parallel to modulate the formation of
α cells during islet development.
An unexpected finding emerged from our characterization
of the glucagon-positive cell population in Nkx2.2−/−;
NeuroD1−/− DKO mice with regards to α cell marker
expression in the Nkx2.2−/− ghrelin cell population. While
Brn4 expression levels corresponded to the presence and
absence of glucagon-producing α cells in each of the
genotypes analyzed, Arx and Irx2 expression levels corre-
sponded more closely with the Nkx2.2−/− ghrelin cell
population. In our previous analyses of the Nkx2.2−/− ghrelin
cells, these two transcription factors had not yet been identified
as α cell markers and were not assessed. It is possible that the
ghrelin-producing cells in the Nkx2.2−/− mice are α cells that
merely misexpress ghrelin; however, none of the ghrelin cells
in the Nkx2.2−/− islets co-express glucagon or Brn4. It is also
possible that Arx and Irx2 are also expressed in wild-type
ghrelin cells, a hypothesis we could not test due to the lack of
Fig. 7. Preproglucagon-producing cells in the intestine also recovered in Nkx2.2−/−;NeuroD1−/−DKOmice. Quantitative PCR of Nkx2.2, NeuroD1, preproglucagon,
secretin, CCK and ghrelin mRNA in P0 intestine of wild-type, NeuroD1−/−, Nkx2.2−/− and Nkx2.2−/−;NeuroD1−/− DKO mice. n=3–6 pancreas per genotype in
qPCR. Significance was calculated using the two-tailed Student's t-test with unequal variance. A p value of b0.05 is indicated by an asterisk (*) compared to wild-type
phenotype.
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however, this explanation is not supported by the phenotype
of the Arx null mice in which there is a loss of glucagon
cells and the glucagon+ghrelin+population, but no effect on
the ghrelin ε cells (Collombat et al., 2003; Heller et al.,
2005). An intriguing possibility is that the ghrelin-producing
cells that form in the Nkx2.2−/− mice represent a novel
bipotential intermediate cell that expresses Arx, but in the
absence of Nkx2.2 cannot inactivate ghrelin and initiate the
expression of Brn4 and glucagon to allow mature α cell
formation. If this is the case, then the simultaneous loss of
NeuroD1 in the Nkx2.2−/− mice may function to partially
suppress this block and allow normal differentiation of α
cells to proceed. While we have yet to resolve this issue and
the mechanism underlying the phenotypes we observe, it
does appear that the loss of NeuroD1 in the Nkx2.2−/−
mice allows the restoration of apparently normal α cells that
express Brn4 and Arx.
Previous studies of the NeuroD1−/− mice have suggested
that NeuroD1 is required for the terminal differentiation of α
and β cells; at birth both these cell populations are significantly
depleted compared to wild-type mice (Chu et al., 2001; Naya
et al., 1997). While the absence of normal numbers of β cells
appears to be caused by increased levels of apoptosis, the
mechanism underlying the decrease in α cell numbers was not
determined, possibly due to the relatively small number of α
cells available for analysis (Naya et al., 1997). We have
demonstrated that the elimination of NeuroD1 in the Nkx2.2−/−
mice restores α cell formation during the secondary transition;
however, α cell numbers never return to wild-type levels. Based
on the previously characterized role for NeuroD1 in the terminal
differentiation of α cells (Naya et al., 1997), we hypothesize
that NeuroD1 also plays a later role in α cell survival that is
independent of Nkx2.2. Alternatively, an additional complex
relationship may exist between NeuroD1 and Nkx2.2 in
maintaining the α cell population, and the loss of Nkx2.2
may partially rescue the survival of NeuroD1-deficient α cells.
The generation of temporal and cell-type-specific knockoutalleles of Nkx2.2 and NeuroD1 will allow us to explore these
questions further.
In summary, a complex and overlapping regulatory network
that requires Nkx2.2 and NeuroD1 determines the cell fate
decisions in the islet and the intestine. A large number of
mutational studies from many labs have uncovered many of the
regulatory factors that contribute to these processes; however,
it is likely that additional regulatory factors and/or novel roles
for known factors have yet to be identified. Using genetic
epistasis analysis, we have demonstrated that Nkx2.2 and
NeuroD1 functionally cooperate during islet cell differentiation
and we have uncovered a novel function for NeuroD1 in the
regulation of α, PP and ε cell fate determination suggesting
there exists a unique interaction between Nkx2.2 and NeuroD1
in these early cell fate decisions. The corresponding decrease in
ε cell numbers that occurs with the increase in α cells in the
Nkx2.2−/−;NeuroD1−/− DKO mice provides further evidence
that Nkx2.2 regulates the cell fate choice between these two
islet lineages and implicates NeuroD1 as mediator of these
important developmental fate decisions. NeuroD1 and Nkx2.2
also appear to interact in their regulation of PP cell fate
determination. It is clear from this analysis that simple single
gene mutations may not uncover the full functional repertoire
of known transcription factors or the full complexities of these
regulatory pathways. Additional studies will be required to
determine epistatic relationships between known and novel
islet factors to gain a complete understanding of their relative
functions in directing pancreatic islet cell fates.
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